No et perdis res!
Uneix-te a la comunitat de wijobs i rep per email les millors ofertes d'ocupació
Mai no compartirem el teu email amb ningú i no t'enviarem correu brossa
Subscriu-te araAdministració i Secretariat
4Informàtica i IT
4Enginyeria i Mecànica
2Instal·lació i Manteniment
2Transport i Logística
2Veure més categories
Comerç i Venda al Detall
1Comercial i Vendes
1Dret i Legal
1Educació i Formació
1Agricultura
0Alimentació
0Art, Moda i Disseny
0Arts i Oficis
0Assegurances
0Atenció al client
0Banca
0Ciència i Investigació
0Comptabilitat i Finances
0Construcció
0Cures i Serveis Personals
0Desenvolupament de Programari
0Disseny i Usabilitat
0Editorial i Mitjans
0Energia i Mineria
0Esport i Entrenament
0Farmacèutica
0Hostaleria
0Immobiliària
0Indústria Manufacturera
0Màrqueting i Negoci
0Producte
0Publicitat i Comunicació
0Recursos Humans
0Sanitat i Salut
0Seguretat
0Social i Voluntariat
0Telecomunicacions
0Turisme i Entreteniment
0Top Zones
Nafarroa
11INGENIEROJOB
Pamplona/Iruña, ES
The “In vivo Organ Generation by Stem Cells” group, led by Dr. Xabier Aranguren at CIMA Universidad de Navarra is looking for a postdoctoral researcher to apply to the Sara Borrell call
INGENIEROJOB · Pamplona/Iruña, ES
.
Descripción de la oferta
The “In vivo Organ Generation by Stem Cells” group, led by Dr. Xabier Aranguren at CIMA Universidad de Navarra is looking for a postdoctoral researcher to apply to the Sara Borrell call
Organ transplantation is a very effective life-saving treatment for end-stage organ diseases. Nevertheless, the number of organs available for transplantations is limited, and the waiting lists are ever increasing, recently counting around 150.000 people Europe and 100.00 in USA, leading to a high rate of death for organ failure: only in the European continent, approximately 5.000 people die every year waiting for an organ, with a mortality rates for patients waiting for a heart, liver or lung ranging between 15 and 30%. The necessity to find additional source of organs for transplantation has boosted research on the generation of organs from pluripotent stem cells (PSCs).
We develop new therapeutic alternatives based on the generation of xeno-organs in vivo, by blastocyst complementation with pluripotent stem cells. This strategy is based on the microinjection of stem cells into genetically modified embryos, incapable of generating a certain organ/cell type. In this way the target organ is formed exclusively from the microinjected stem cells. The group works with mouse and rat embryonic stem cells and human iPS cells, as well as with genetically modified mouse and pig models.
Last Publications
- https://pubmed.ncbi.nlm.nih.gov/40551151/
- https://pubmed.ncbi.nlm.nih.gov/37967560/
- https://pubmed.ncbi.nlm.nih.gov/37660554/
- https://pubmed.ncbi.nlm.nih.gov/36563688/
- https://pubmed.ncbi.nlm.nih.gov/35883376/
The candidate must have a PhD degree in Sciences (Biology, Biochemistry, Pharmacy, Biotechnology…) with a strong track record of high quality biomedical research.
Note: CV and motivational letter required
Regístrate para ver la oferta completa
Comparte En Tus Redes Sociales
Tweet
Compartir